Prime Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Prime Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 5 Products, $1.3M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Prime Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 5 Products, $1.3M Trade | TransData Nexus

Prime Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $1.3M Total Trade · DGFT Verified

Prime Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $1.3M across 5 products in 4 therapeutic categories. Based on 74 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Fluticasone ($453.4K), Vitamin ($450.0K), Salmeterol ($215.3K).

Prime Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Prime Pharmaceuticals Private Limited pharmaceutical export portfolio — 5 products across 4 therapeutic categories. Source: Indian Customs (DGFT).

Who is Prime Pharmaceuticals Private Limited? — Company Overview & Market Position

Prime Pharmaceuticals Private Limited, established on September 11, 1995, is a privately held Indian pharmaceutical company headquartered in Mumbai, Maharashtra. The company is registered under the Corporate Identification Number (CIN) U24231MH1995PTC092543. As of the latest available data, Prime Pharmaceuticals has an authorized capital of ₹20 million and a paid-up capital of ₹6.318 million. The company operates in the manufacturing of chemical substances used in pharmaceuticals, including antibiotics, endocrine products, basic vitamins, and other related products.

The registered office is located at 601, 6th Floor, Kamla Executive Park, A K Road, Andheri East, Mumbai, Maharashtra 400059, India. Prime Pharmaceuticals has a global presence, exporting to over 50 countries, and is committed to delivering high-quality, cost-effective healthcare solutions.

What Does Prime Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Fluticasone$453.4K 2

Product Portfolio — Top 5 by Export Value

Prime Pharmaceuticals Private Limited exports 5 pharmaceutical products across 4 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Fluticasone	Respiratory	$453.4K	35	0.2%	9
2	Vitamin	Nutritional Supplements	$450.0K	9	0.3%	13
3	Salmeterol	Respiratory	$215.3K	21	0.3%	14
4	Cisplatin	Oncology	$150.0K	3	1.2%	14
5	Bleomycin	Advanced Oncology	$78.3K	6	1.4%	12

Prime Pharmaceuticals Private Limited exports 5 pharmaceutical products across 4 therapeutic categories with a total export value of $1.3M. The top category is Respiratory (49.6% of portfolio), followed by Nutritional Supplements (33.4%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Prime Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Prime Pharmaceuticals operates state-of-the-art manufacturing facilities in India, adhering to stringent quality standards. The company specializes in the production of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. These facilities are equipped with advanced technology to ensure the production of high-quality products. While specific details regarding plant locations and capacities are not publicly disclosed, the company's commitment to quality is evident through its adherence to global regulatory standards.

3Key Leadership

The leadership team at Prime Pharmaceuticals Private Limited comprises experienced professionals dedicated to the company's growth and success. Key executives include:

Ashish Anil Vora: Director since September 11, 1995.

Devang Subodh Thakar: Director since April 2, 1998.

Manish Patel: Director since April 2, 1998.

Manish Navnitrai Vora: Director since May 23, 2024.

Ramamurthy Ayyavuthevar: Director since February 5, 2021.

Irfan Vazirally: Director since May 20, 2022.

The leadership team's extensive experience in the pharmaceutical industry contributes to the company's strategic direction and operational excellence.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Prime Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Prime Pharmaceuticals Private Limited has established a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company has filed numerous dossiers annually, indicating a robust pipeline of regulatory submissions. While specific details regarding regulatory approvals in these markets are not publicly disclosed, the company's participation in international exhibitions, such as iPHEX India 2025, underscores its commitment to global market expansion and compliance with international standards.

2Emerging Markets

Prime Pharmaceuticals has strategically expanded its footprint in emerging markets across Africa, Latin America, and Southeast Asia. The appointment of Ms. Amrita Bhat as Vice President – Sales, Marketing, and Business Development for the Africa Region in October 2025 highlights the company's focus on these regions. Ms. Bhat's extensive experience in the African market is expected to drive growth and enhance access to healthcare in these emerging markets.

3Geographic Strategy

Prime Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Prime Pharmaceuticals' FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available. However, the company's participation in international exhibitions and its global export activities suggest a commitment to meeting international regulatory standards.

2WHO & EU GMP

While specific certifications such as WHO prequalification and EU Good Manufacturing Practice (GMP) certificates are not publicly disclosed, Prime Pharmaceuticals' adherence to global regulatory standards is evident through its extensive export activities and participation in international exhibitions. The company's commitment to quality and compliance underscores its dedication to meeting international manufacturing standards.

3CDSCO & Indian Regulatory

Prime Pharmaceuticals holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), the national regulatory authority in India. The company's compliance with Indian regulatory standards is further demonstrated by its active status and adherence to the Companies Act, as indicated by its Corporate Identification Number (CIN) U24231MH1995PTC092543.

Prime Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Prime Pharmaceuticals operates in a competitive landscape with numerous pharmaceutical companies offering similar products. While specific market share data is not publicly available, the company's diverse product portfolio and global export activities position it as a significant player in the pharmaceutical industry. The company's focus on quality, innovation, and customer-centric approaches contributes to its competitive edge.

2Key Differentiators

Prime Pharmaceuticals' key differentiators include its commitment to quality, innovation, and customer-centric approaches. The company's extensive export activities and participation in international exhibitions highlight its global reach and dedication to meeting international standards. These factors contribute to its competitive advantages in the pharmaceutical industry.

3Strategic Position

Prime Pharmaceuticals' strategic direction focuses on expanding its global footprint through exports to over 50 countries, including both developed and emerging markets. The company's participation in international exhibitions and the appointment of experienced leaders for regional markets underscore its commitment to growth and market diversification. The future outlook appears positive, with a focus on innovation, quality, and customer satisfaction driving the company's strategic initiatives.

Buyer Due Diligence Brief — Evaluating Prime Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Prime Pharmaceuticals demonstrates a strong track record in the pharmaceutical industry, with over 30 years of experience. The company's export volume and consistency are evident through its presence in over 50 countries and participation in international exhibitions. Reliability indicators include adherence to global regulatory standards and a commitment to quality, as reflected in its product offerings and customer-centric approach.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Registration: Confirm the company's FDA facility registration status through the FDA's official website.

WHO-GMP Certification: Verify WHO Good Manufacturing Practice certification through the World Health Organization's official channels.

EU GMP Certification: Check for EU Good Manufacturing Practice certification via the European Medicines Agency's official resources.

Frequently Asked Questions — Prime Pharmaceuticals Private Limited

How many pharmaceutical products does Prime Pharmaceuticals Private Limited export from India?

Prime Pharmaceuticals Private Limited exports 5 pharmaceutical products across 4 therapeutic categories. The top exports are Fluticasone ($453.4K), Vitamin ($450.0K), Salmeterol ($215.3K), Cisplatin ($150.0K), Bleomycin ($78.3K). Total export value is $1.3M.

What is Prime Pharmaceuticals Private Limited's total pharmaceutical export value?

Prime Pharmaceuticals Private Limited's total pharmaceutical export value is $1.3M, based on 74 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Prime Pharmaceuticals Private Limited cover?

Prime Pharmaceuticals Private Limited exports across 4 therapeutic categories. The largest are Respiratory (49.6%, 2 products), Nutritional Supplements (33.4%, 1 products), Oncology (11.1%, 1 products).

Get Full Prime Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.